Straumann Holding AG

QS51

Company Profile

  • Business description

    Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

  • Contact

    Peter Merian-Weg 12
    Basel4002
    CHE

    T: +41 619651111

    E: [email protected]

    https://www.straumann-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    11,824

Stocks News & Analysis

stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.
stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.
stocks

This onetime AI market darling is now surprisingly undervalued

This AI leader qualifies as a GARP stock today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,178.4069.700.77%
CAC 408,613.82104.181.22%
DAX 4026,001.31372.071.45%
Dow JONES (US)53,130.71645.681.23%
FTSE 10010,857.7010.35-0.10%
HKSE26,009.40124.970.48%
NASDAQ25,920.18546.332.15%
Nikkei 22563,754.90607.12-0.94%
NZX 50 Index13,774.9375.650.55%
S&P 5007,600.77111.051.48%
S&P/ASX 2009,019.3070.300.79%
SSE Composite Index3,809.6622.60-0.59%

Market Movers